The majority of the SLE cohort met the following classification criteria (Figure 1), each assessed historically: ANA (97.1%), arthritis (89.5%), anti-dsDNA (57.1%) and photosensitivity (47.6%). This evidence concerns the gene BTG3 and systemic lupus erythematosus.